beta
Trial Radar AI
Clinical Trial NCT07493187 for Interstitial Lung Disease is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Magnetic Resonance Imaging of the Lung: Non-Oncological Applications 50

Recruiting
Clinical Trial NCT07493187 is an observational study for Interstitial Lung Disease that is recruiting. It started on December 28, 2020 with plans to enroll 50 participants. Led by Fondazione IRCCS Policlinico San Matteo di Pavia, it is expected to complete by April 28, 2026. The latest data from ClinicalTrials.gov was last updated on March 25, 2026.
Brief Summary
Non-neoplastic pulmonary proliferative diseases are characterized by a complex interaction between proliferating lung cells and a variety of resident and infiltrating host cells, secreted factors, and extracellular matrix proteins, collectively referred to as the microenvironment. Idiopathic pulmonary fibrosis (IPF) refers to a specific condition characterized by chronic interstitial pneumonia and fibrosis of unknown...Show More
Official Title

Magnetic Resonance Imaging of the Lung: Non-Oncological Applications

Conditions
Interstitial Lung Disease
Other Study IDs
  • P_113422
NCT ID Number
NCT07493187
Start Date (Actual)
2020-12-28
Last Update Posted
2026-03-25
Completion Date (Estimated)
2026-04-28
Enrollment (Estimated)
50
Study Type
Observational
Status
Recruiting
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Assessment of the ability of advanced magnetic resonance imaging techniques to assess tissue oxygenation and local hypoxia in early interstitial pulmonary fibrosis (proliferative stage)
up to 36 months
Participation Assistant
Eligibility Criteria

Eligible Ages
Child, Adult, Older Adult
Eligible Sexes
All
  • Clinical and radiological diagnosis of early-stage IPF

  • Absolute contraindications to bronchoalveolar lavage or magnetic resonance imaging
Fondazione IRCCS Policlinico San Matteo di Pavia logoFondazione IRCCS Policlinico San Matteo di Pavia
Study Responsible Party
Chandra Bortolotto, Principal Investigator, Principal Investigator, Fondazione IRCCS Policlinico San Matteo di Pavia
No contact data.
1 Study Locations in 1 Countries

Lombardy

Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, Lombardy, 27100, Italy
Chandra Bortolotto, MD, Contact, 0382503761, [email protected]
Recruiting